Oct 8, 2010 - ESMO Congress. Milan (Italy). 8-12 October 2010   
MolMed delegation will attend the congress


Sept 29, 2010 - Biotech in Europe Investor Forum. Zurich (Switzerland). 29-30 September 2010   
MolMed Business Development Director will give a company presentation


Sept 21, 2010 - III Italian Stock Market Opportunities Conference. Milan (Italy). 21-22 September 2010.   MolMed Business Development Director will attend the congress


Jun 28, 2010 - Euro-Biotech Forum. Paris (France). 28-30 June 2010   MolMed delegation attended the congress


Jun 8, 2010 - Presentation at Jefferies Conference. New York (USA). 8-11 June 2010   


Jun 4, 2010 - ASCO Annual Meeting. Chicago (IL, USA). 4-8 June 2010   
MolMed CEO presented a poster entitled "Thymic renewal and antileukemic effect in adults after haploidentical transplantation and suicide gene therapy" during the session "Leukemia, Myelodysplasya, and Transplantation"


May 19, 2010 - BioEquity Europe. Zurich (Switzerland). 19-20 May 2010   MolMed Business Development & Investor Relations Director gave a company presentation


May 12, 2010 - MolMed company presentation - Milan May 12, 2010   


May 3, 2010 - BIO. Chicago (IL, USA). 3-6 May 2010   
MolMed Business Development Director gave a company presentation


Apr 17, 2010 - American Association for Cancer Research (AACR) Annual Meeting. Washington (USA). 17-21 April 2010   MolMed presented an abstract in session: "Angiogenic Inhibitors: Resistance and Biomarkers".
Abstract title: "Both NGR and TNF portions of NGR-TNF contribute to tumor vessel specific homing and apoptosis in vivo".
Poster presentation was cancelled due to the impossibility to attend the conference



Apr 17, 2010 - American Association for Cancer Research (AACR) Annual Meeting. Washington (USA). 17-21 April 2010   
MolMed presented an abstract in session: "Drug Design and Target Validation".
Abstract title: "Development and application of novel in silico methods in the discovery and characterization of integrins antagonists".
Poster presentation was cancelled due to the impossibility to attend the conference




Mar 8, 2010 - Bio Europe Spring. Barcelona (Spain). 8-10 March 2010   
MolMed Business Development Manager gave a company presentation


Feb 8, 2010 - Annual BIO CEO & Investor Conference. New York. 8-9 February 2010   
9 February - MolMed CEO gave a company presentation.


Feb 2, 2010 - 12th International Symposium on Anti-Angiogenic Agents. San Diego (CA). 2-4 February 2010   
MolMed Research Director presented a poster on the mechanism of action of NGR-hTNF.


Feb 1, 2010 - BioSquare. Geneve (Switzerland). 1-2 February 2010   
MolMed Business Development Director attended the meeting


Jan 25, 2010 - Cell & Gene Therapy Forum. Wahington (USA). 25-27 January 2010   
- 25 Jan, h 9.35: MolMed CEO took part to roundtable: "How will cell therapies, gene therapies and tissue-engineered products fit in to a reforming healthcare picture? Examining the commercialization strategies of companies in pivotal trials".
- 25 Jan, h 14.50: MolMed CEO gave a presentation in the session: "Gene therapy clinical update: analyzing recent clinical success stories in key therapeutic areas to inform your trial design strategy".

ARCHIVE

| 2010 | 2009 | 2008 | 2007 |